The national program of health evaluation and promotion is supposed to start in 2008. The program mentions to detect impaired glucose metabolism, i.e. firstly either fasting blood glucose (FBS) or HbA
1c may be chosen, secondly if both FBS and HbA
1c are measured, value of FBS takes precedence over HbA
1c. Using our data in 2006, we examined the policy.
Among the subjects whose FBS and HbA
1c were checked simultaneously, 410 were referred to medical facilities for further examination or treatment according to a certain criteria, i.e. FBS of 126 mg/d
l or higher and/or HbA
lc of 6.1% or higher.
The results of further or re-examination were sent back in 235 subjects (57.3%) . Among 108 subjects with FBS of 126 mg/d
l or higher, 86 (79.6%) were diagnosed as diabetes mellitus (DM) . On the other hand, 172 (83.1%) were diagnosed as DM among 207 subjects with HbA
1c of 6.1% or higher. Diagnostic efficiency of DM is not significantly different between FBS and HbA
1c.
In 235 subjects, only FBS, or only HbA
1c or both FBS and HbA
1c meat the criteria were 28 (FBS group), 127 (HbA
1c group), and 80 (FBS + HbA
1c group), respectively.
A hundred and eighty three subjects were diagnosed as DM, 11 in FBS group (39.3%), 97 in HbA
1c group (76.4%), and 75 in FBS + HbA
1c group (93.7%) . Diagnostic efficiency of DM in HbA
1c group was better than in FBS group (
p < 0.005), and the efficiency in FBS + HbA
1c group was also better than both in FBS group and in HbA
1c group (
p < 0.005, respectively) . If FBS only is examined to detect DM, 97 (53.0%) out of 183 subjects with DM must have been missed. The cost-effectiveness analysis also suggests the usefulness to examine HbA
1c.
Our data suggest that HbA
1c is indispensable to detect DM in health examination, and also both FBS and HbA
1c should be measured in the health examination program.
View full abstract